Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Furukawa

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Biochimica Et Biophysica Acta|November 6, 2002
Beta1,4-N-acetylgalactosaminyltransferase--GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosidesKoichi Furukawa, Kogo Takamiya, Keiko Furukawa
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|June 17, 2003
[Function of gangliosides]Koichi Furukawa, Masashi Nishio, Keiko Furukawa
Translational Cancer Research|February 7, 2022
Erratum to anti-GD2 CAR T cells could prove transformative for H3-K27M<sup>+</sup> diffuse midline gliomasKoichi Furukawa, Yuhsuke Ohmi, Keiko Furukawa
Methods in Enzymology|November 30, 2006
Roles of glycolipids in the development and maintenance of nervous tissuesKoichi Furukawa, Tetsuya Okuda, Keiko Furukawa
Translational Cancer Research|February 4, 2022
Anti-GD2 CAR T cells could prove transformative for H3-K27M<sup>+</sup> diffuse midline gliomasKoichi Furukawa, Yuhsuke Ohmi, Keiko Furukawa
Cancer Research|June 3, 2011
Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigenYoshio Yamauchi, Keiko Furukawa, Kazunori Hamamura, et al.
Glycoconjugate Journal|August 7, 2008
Glycoconjugate glycosyltransferasesKoichi Furukawa, Akiko Tsuchida, Tetsuya Okajima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Drug discovery sciences in Japan with focus on molecular-targeted drugs]Koichi Furukawa, Kazunori Hamamura, Yuki Ohkawa, et al.
Biochimica Et Biophysica Acta|May 28, 2005
Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxinsMasaru Kitamura, Shizunobu Igimi, Keiko Furukawa, et al.
Proteomics|August 12, 2008
Molecules in the signaling pathway activated by gangliosides can be targets of therapeutics for malignant melanomasKoichi Furukawa, Kazunori Hamamura, Hideyuki Nakashima, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Biochimica Et Biophysica Acta|November 6, 2002
Beta1,4-N-acetylgalactosaminyltransferase--GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosidesKoichi Furukawa, Kogo Takamiya, Keiko Furukawa
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|June 17, 2003
[Function of gangliosides]Koichi Furukawa, Masashi Nishio, Keiko Furukawa
Translational Cancer Research|February 7, 2022
Erratum to anti-GD2 CAR T cells could prove transformative for H3-K27M<sup>+</sup> diffuse midline gliomasKoichi Furukawa, Yuhsuke Ohmi, Keiko Furukawa
Methods in Enzymology|November 30, 2006
Roles of glycolipids in the development and maintenance of nervous tissuesKoichi Furukawa, Tetsuya Okuda, Keiko Furukawa
Translational Cancer Research|February 4, 2022
Anti-GD2 CAR T cells could prove transformative for H3-K27M<sup>+</sup> diffuse midline gliomasKoichi Furukawa, Yuhsuke Ohmi, Keiko Furukawa
Cancer Research|June 3, 2011
Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigenYoshio Yamauchi, Keiko Furukawa, Kazunori Hamamura, et al.
Glycoconjugate Journal|August 7, 2008
Glycoconjugate glycosyltransferasesKoichi Furukawa, Akiko Tsuchida, Tetsuya Okajima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Drug discovery sciences in Japan with focus on molecular-targeted drugs]Koichi Furukawa, Kazunori Hamamura, Yuki Ohkawa, et al.
Biochimica Et Biophysica Acta|May 28, 2005
Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxinsMasaru Kitamura, Shizunobu Igimi, Keiko Furukawa, et al.
Proteomics|August 12, 2008
Molecules in the signaling pathway activated by gangliosides can be targets of therapeutics for malignant melanomasKoichi Furukawa, Kazunori Hamamura, Hideyuki Nakashima, et al.
Pageof 15